FDA OCE Announces Project Interface Outreach Initiative

The Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA) has initiated Project Interface, aiming to enhance engagement with cancer patients, advocacy groups, and experts globally. Their mission is to safeguard public health by facilitating interactions and sharing crucial cancer-related information. Project Interface focuses on 'Making Cancer Personal at the FDA' and invites patient advocacy groups and organizations to engage in discussions regarding patient experiences, collaborations with regulators, and strategies for promoting cancer awareness.